1. Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age. Issue 31 (17th July 2015) Authors: Janssen, Julia M.; Jackson, Sam; Heyward, William L.; Janssen, Robert S. Journal: Vaccine Issue: Volume 33:Issue 31(2015) Page Start: 3614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗